We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

By LabMedica International staff writers
Posted on 20 Jun 2025

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. More...

Since most treatments only slow disease progression, early diagnosis is critical for effective care. Now, researchers have developed a novel and affordable screening system that detects PD from the volatile organic compounds (VOCs) found in a person’s earwax.

This innovative approach from researchers at Zhejiang University (Hangzhou, China;) was the result of a study to explore the diagnostic potential of sebum-rich earwax as a more stable and protected source of VOCs linked to Parkinson’s. The idea builds on earlier findings that sebum composition changes in PD due to neurodegeneration, inflammation, and oxidative stress, resulting in a distinctive odor profile. Unlike facial sebum, which is exposed to external environmental conditions such as humidity and air pollution, earwax remains relatively uncontaminated, making it a reliable testing medium. To investigate this, the researchers collected earwax samples by swabbing the ear canals of 209 individuals, including 108 people diagnosed with PD. Using gas chromatography and mass spectrometry, they identified four VOCs that were significantly different in people with Parkinson’s: ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. These VOCs emerged as potential biomarkers for the disease.

Based on this dataset, the team developed an artificial intelligence olfactory (AIO) system trained to detect PD by analyzing the VOC patterns. When tested, the AIO-based model demonstrated 94% accuracy in distinguishing between PD and non-PD samples, according to the ACS’ Analytical Chemistry report. The high level of precision highlights the system’s potential for early detection, especially since the test is non-invasive and inexpensive. This new AIO screening tool could serve as a first-line diagnostic method to catch PD in its earliest stages, well before traditional symptoms appear. By enabling earlier medical intervention, it may improve long-term care outcomes for patients and streamline diagnosis in both clinical and community healthcare settings.

“This method is a small-scale single-center experiment in China,” said researcher Hao Dong from Zhejiang University. “The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value.”


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.